KaydedilenlerDerginizi ekleyin

Dergiler / Göztepe Tıp Dergisi / 2007 / Cilt: 22 - Sayı: 4

Kronik hepatit B'de peginterferon tedavisi

HBsAg seroconversion with pegylated interferon treatment for chronic hepatitis B

Yılmaz Feruze ENÇ, Canan YEŞİLOĞLU

Sayfa
156–157
DOI
—

Abstract

Each year HBsAg seroconversion appears spontenously between the range of 1-2 percent and also antiHBs appears in 1/3 of these cases. HBsAg seroconversion is % 4 for the treatment with convensional interferon and this rate is also similar for the treatment with pegylated interferon. Here we present a patient with chronic hepatitis B who treated with pegylated interferon, had seroconversion of HBsAg.